ArQule Inc Reveals Experimental Colorectal Cancer Drug Fails to Extend Survival in Trial

by Kathy Jones on  January 12, 2013 at 8:02 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

American drug maker ArQule Inc revealed that its experimental colorectal cancer drug, developed in collaboration with Japan's Daiichi Sankyo Co Ltd, has failed to achieve its main goal of extending the progression-free survival period in patients in a trial.
 ArQule Inc Reveals Experimental Colorectal Cancer Drug Fails to Extend Survival in Trial
ArQule Inc Reveals Experimental Colorectal Cancer Drug Fails to Extend Survival in Trial

The experimental drug, known as tivantinib, was ArQule's lead candidate with the company also hoping that the drug could be used in treating hepatocellular carcinoma or liver cancer.

The company said that while the drug was able to slightly improve the progression free survival period in the trial, which included 122 patients with refractory or relapsed colorectal cancer, the improvement was not significant enough.

Daiichi's Reinhard von Roemeling tried to remain positive, stating that they will now be looking at how to best proceed in improving the drug. "We are encouraged by these findings. We plan to continue discussions to determine how best to proceed with further clinical development of tivantinib in this tumor type", he said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Cancer and Homeopathy Colo-rectal cancer - Management Colorectal Cancer Signature Drug Toxicity Cancer Facts Cancer Tattoos A Body Art Colon Polyps Colorectal Cancer Screening 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive